[Cytoprotective action of prostaglandins].
D000818:Animals; D001241:Aspirin / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004381:Duodenal Ulcer / Q000188:drug therapy; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D009093:Mucus / Q000187:drug effects / Q000378:metabolism; D009336:Necrosis; D011239:Prednisolone / Q000009:adverse effects; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use*; D051381:Rats; D013276:Stomach Ulcer / Q000188:drug therapy
D011465:Prostaglandins, Synthetic; D011239:Prednisolone; D001241:Aspirin; D007213:Indomethacin
Tsitoprotektivnoe deĭstvie prostaglandinov.